Skip to main content
Top
Published in: European Radiology 3/2020

Open Access 01-03-2020 | Prostate Cancer | Imaging Informatics and Artificial Intelligence

Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer

Authors: Jeroen Bleker, Thomas C. Kwee, Rudi A. J. O. Dierckx, Igle Jan de Jong, Henkjan Huisman, Derya Yakar

Published in: European Radiology | Issue 3/2020

Login to get access

Abstract

Objectives

To create a radiomics approach based on multiparametric magnetic resonance imaging (mpMRI) features extracted from an auto-fixed volume of interest (VOI) that quantifies the phenotype of clinically significant (CS) peripheral zone (PZ) prostate cancer (PCa).

Methods

This study included 206 patients with 262 prospectively called mpMRI prostate imaging reporting and data system 3–5 PZ lesions. Gleason scores > 6 were defined as CS PCa. Features were extracted with an auto-fixed 12-mm spherical VOI placed around a pin point in each lesion. The value of dynamic contrast-enhanced imaging(DCE), multivariate feature selection and extreme gradient boosting (XGB) vs. univariate feature selection and random forest (RF), expert-based feature pre-selection, and the addition of image filters was investigated using the training (171 lesions) and test (91 lesions) datasets.

Results

The best model with features from T2-weighted (T2-w) + diffusion-weighted imaging (DWI) + DCE had an area under the curve (AUC) of 0.870 (95% CI 0.980–0.754). Removal of DCE features decreased AUC to 0.816 (95% CI 0.920–0.710), although not significantly (p = 0.119). Multivariate and XGB outperformed univariate and RF (p = 0.028). Expert-based feature pre-selection and image filters had no significant contribution.

Conclusions

The phenotype of CS PZ PCa lesions can be quantified using a radiomics approach based on features extracted from T2-w + DWI using an auto-fixed VOI. Although DCE features improve diagnostic performance, this is not statistically significant. Multivariate feature selection and XGB should be preferred over univariate feature selection and RF. The developed model may be a valuable addition to traditional visual assessment in diagnosing CS PZ PCa.

Key Points

• T2-weighted and diffusion-weighted imaging features are essential components of a radiomics model for clinically significant prostate cancer; addition of dynamic contrast-enhanced imaging does not significantly improve diagnostic performance.
• Multivariate feature selection and extreme gradient outperform univariate feature selection and random forest.
• The developed radiomics model that extracts multiparametric MRI features with an auto-fixed volume of interest may be a valuable addition to visual assessment in diagnosing clinically significant prostate cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30 Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30
3.
go back to reference van den Bergh R, Loeb S, Roobol MJ (2015) Impact of early diagnosis of prostate cancer on survival outcomes. Eur Urol Focus 1:137–146PubMed van den Bergh R, Loeb S, Roobol MJ (2015) Impact of early diagnosis of prostate cancer on survival outcomes. Eur Urol Focus 1:137–146PubMed
4.
go back to reference Harvey P, Basuita A, Endersby D, Curtis B, Iacovidou A, Walker M (2009) A systematic review of the diagnostic accuracy of prostate specific antigen. BMC Urol 9:1–9 Harvey P, Basuita A, Endersby D, Curtis B, Iacovidou A, Walker M (2009) A systematic review of the diagnostic accuracy of prostate specific antigen. BMC Urol 9:1–9
5.
go back to reference Pokorny MR, De Rooij M, Duncan E et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent mr-guided biopsy in men without previous prostate biopsies. Eur Urol 66:22–29PubMed Pokorny MR, De Rooij M, Duncan E et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent mr-guided biopsy in men without previous prostate biopsies. Eur Urol 66:22–29PubMed
6.
go back to reference Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876–892PubMed Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64:876–892PubMed
7.
go back to reference Oberlin DT, Casalino DD, Miller FH, Meeks JJ (2017) Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom Radiol (NY) 42:1255–1258 Oberlin DT, Casalino DD, Miller FH, Meeks JJ (2017) Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom Radiol (NY) 42:1255–1258
8.
go back to reference Thompson JE, Van Leeuwen PJ, Moses D et al (2016) The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer. J Urol 195:1428–1435PubMed Thompson JE, Van Leeuwen PJ, Moses D et al (2016) The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer. J Urol 195:1428–1435PubMed
9.
go back to reference Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815–822PubMed Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815–822PubMed
10.
go back to reference Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging - reporting and data system: 2015, Version 2. Eur Urol 69:16–40PubMed Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS Prostate Imaging - reporting and data system: 2015, Version 2. Eur Urol 69:16–40PubMed
11.
go back to reference Kasel-Seibert M, Lehmann T, Aschenbach R et al (2016) Assessment of PI-RADS v2 for the detection of prostate cancer. Eur J Radiol 85:726–731PubMed Kasel-Seibert M, Lehmann T, Aschenbach R et al (2016) Assessment of PI-RADS v2 for the detection of prostate cancer. Eur J Radiol 85:726–731PubMed
12.
go back to reference Hofbauer SL, Kittner B, Maxeiner A et al (2018) Validation of Prostate Imaging Reporting and Data System version 2 for the detection of prostate cancer. J Urol 200:767–773PubMed Hofbauer SL, Kittner B, Maxeiner A et al (2018) Validation of Prostate Imaging Reporting and Data System version 2 for the detection of prostate cancer. J Urol 200:767–773PubMed
13.
go back to reference van der Leest M, Cornel E, Israël B et al (2018) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective mu. Eur Urol 5:579–581 van der Leest M, Cornel E, Israël B et al (2018) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective mu. Eur Urol 5:579–581
14.
go back to reference Rouvière O, Puech P, Renard-Penna R et al (2018) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100–109PubMed Rouvière O, Puech P, Renard-Penna R et al (2018) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100–109PubMed
16.
go back to reference Aerts HJWL, Velazquez ER, Leijenaar RTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006PubMedPubMedCentral Aerts HJWL, Velazquez ER, Leijenaar RTH et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006PubMedPubMedCentral
17.
go back to reference Cameron A, Khalvati F, Haider MA, Wong A (2016) MAPS: a quantitative radiomics approach for prostate cancer detection. IEEE Trans Biomed Eng 63:1145–1156PubMed Cameron A, Khalvati F, Haider MA, Wong A (2016) MAPS: a quantitative radiomics approach for prostate cancer detection. IEEE Trans Biomed Eng 63:1145–1156PubMed
18.
go back to reference Khalvati F, Zhang J, Chung AG, Shafiee MJ, Wong A, Haider MA (2018) MPCaD: a multi-scale radiomics-driven framework for automated prostate cancer localization and detection. BMC Med Imaging 18:16 Khalvati F, Zhang J, Chung AG, Shafiee MJ, Wong A, Haider MA (2018) MPCaD: a multi-scale radiomics-driven framework for automated prostate cancer localization and detection. BMC Med Imaging 18:16
19.
go back to reference Bonekamp D, Kohl S, Wiesenfarth M et al (2018) Radiomic machine learning for characterization of prostate lesions with MRI: comparison to ADC values. Radiology 289:128–137PubMed Bonekamp D, Kohl S, Wiesenfarth M et al (2018) Radiomic machine learning for characterization of prostate lesions with MRI: comparison to ADC values. Radiology 289:128–137PubMed
21.
go back to reference Bennasar M, Hicks Y, Setchi R (2015) Feature selection using joint mutual information maximisation. Expert Syst Appl 42:8520–8532 Bennasar M, Hicks Y, Setchi R (2015) Feature selection using joint mutual information maximisation. Expert Syst Appl 42:8520–8532
22.
go back to reference Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJWL (2015) Machine learning methods for quantitative radiomic biomarkers. Sci Rep 5:1–11 Parmar C, Grossmann P, Bussink J, Lambin P, Aerts HJWL (2015) Machine learning methods for quantitative radiomic biomarkers. Sci Rep 5:1–11
24.
go back to reference Armato SG Jr, Huisman H, Drukker K et al (2018) PROSTATEx challenges for computerized classification of prostate lesions from multiparametric magnetic resonance images. J Med Imaging (Bellingham) 5:044501 Armato SG Jr, Huisman H, Drukker K et al (2018) PROSTATEx challenges for computerized classification of prostate lesions from multiparametric magnetic resonance images. J Med Imaging (Bellingham) 5:044501
25.
go back to reference Litjens G, Debats O, Barentsz J, Karssemeijer N, Huisman H (2014) Computer-aided detection of prostate cancer in MRI. IEEE Trans Med Imaging 33:1083–1092PubMed Litjens G, Debats O, Barentsz J, Karssemeijer N, Huisman H (2014) Computer-aided detection of prostate cancer in MRI. IEEE Trans Med Imaging 33:1083–1092PubMed
26.
27.
28.
go back to reference Wolters T, Roobol MJ, Van Leeuwen PJ et al (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185:121–125PubMed Wolters T, Roobol MJ, Van Leeuwen PJ et al (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185:121–125PubMed
29.
go back to reference Zwanenburg A, Leger S, Vallières M, Löck S (2016) Image biomarker standardisation initiative. ArXiv ID: 1612.07003 Zwanenburg A, Leger S, Vallières M, Löck S (2016) Image biomarker standardisation initiative. ArXiv ID: 1612.07003
30.
go back to reference Van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107PubMedPubMedCentral Van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107PubMedPubMedCentral
31.
go back to reference Barth BK, De Visschere PJL, Cornelius A et al (2017) Detection of clinically significant prostate cancer: short dual– pulse sequence versus standard multiparametric MR imaging—a multireader study Radiology 284:725–736PubMedPubMedCentral Barth BK, De Visschere PJL, Cornelius A et al (2017) Detection of clinically significant prostate cancer: short dual– pulse sequence versus standard multiparametric MR imaging—a multireader study Radiology 284:725–736PubMedPubMedCentral
33.
go back to reference Guyon I, Elisseeff A (2003) An introduction to variable and feature selection. J Mach Learn Res 3:1157–1182 Guyon I, Elisseeff A (2003) An introduction to variable and feature selection. J Mach Learn Res 3:1157–1182
34.
go back to reference Chen JS, Huertas A, Medioni G (1987) Fast convolution with Laplacian-of-Gaussian masks. IEEE Trans Pattern Anal Mach Intell PAMI-9:584–590 Chen JS, Huertas A, Medioni G (1987) Fast convolution with Laplacian-of-Gaussian masks. IEEE Trans Pattern Anal Mach Intell PAMI-9:584–590
35.
go back to reference Thawani R, McLane M, Beig N et al (2018) Radiomics and radiogenomics in lung cancer: a review for the clinician. Lung Cancer 115:34–41PubMed Thawani R, McLane M, Beig N et al (2018) Radiomics and radiogenomics in lung cancer: a review for the clinician. Lung Cancer 115:34–41PubMed
36.
go back to reference Bartušek K, Přinosil J, Smékal Z (2011) Wavelet-based de-noising techniques in MRI. Comput Methods Programs Biomed 104:480–488PubMed Bartušek K, Přinosil J, Smékal Z (2011) Wavelet-based de-noising techniques in MRI. Comput Methods Programs Biomed 104:480–488PubMed
37.
go back to reference Ojala T, Pietikäinen M, Harwood D (1996) A comparative study of texture measures with classification based on featured distributions. Pattern Recognit 29:51–59 Ojala T, Pietikäinen M, Harwood D (1996) A comparative study of texture measures with classification based on featured distributions. Pattern Recognit 29:51–59
38.
39.
go back to reference Shapiro ASS, Wilk MB (1965) An Analysis of Variance Test for Normality (Complete Samples). Biometrika 52:591–611 Shapiro ASS, Wilk MB (1965) An Analysis of Variance Test for Normality (Complete Samples). Biometrika 52:591–611
40.
go back to reference Wilcoxon F (1946) Individual comparisons of grouped data by ranking methods. J Econ Entomol 39:269PubMed Wilcoxon F (1946) Individual comparisons of grouped data by ranking methods. J Econ Entomol 39:269PubMed
41.
go back to reference Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77 Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:77
43.
go back to reference Sackett J, Choyke PL, Turkbey B (2019) Prostate imaging reporting and data system version 2 for MRI of prostate cancer: can we do better? AJR Am J Roentgenol 212:1–9 Sackett J, Choyke PL, Turkbey B (2019) Prostate imaging reporting and data system version 2 for MRI of prostate cancer: can we do better? AJR Am J Roentgenol 212:1–9
44.
go back to reference Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 0232:1–12 Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 0232:1–12
45.
go back to reference Ahonen T, Hadid A, Pietikäinen M (2004) Face recognition with local binary patterns. Comput Vis ECCV 2004:469–481 Ahonen T, Hadid A, Pietikäinen M (2004) Face recognition with local binary patterns. Comput Vis ECCV 2004:469–481
46.
go back to reference Xu M, Fang M, Zou J et al (2019) Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions. Eur J Radiol 114:38–44PubMed Xu M, Fang M, Zou J et al (2019) Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions. Eur J Radiol 114:38–44PubMed
47.
go back to reference DeSouza NM, Winfield JM, Waterton JC et al (2018) Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives. Eur Radiol 28:1118–1131PubMed DeSouza NM, Winfield JM, Waterton JC et al (2018) Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives. Eur Radiol 28:1118–1131PubMed
48.
go back to reference Sasaki M, Yamada K, Watanabe Y et al (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 249:624–630PubMed Sasaki M, Yamada K, Watanabe Y et al (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 249:624–630PubMed
49.
go back to reference Ginsburg SB, Algohary A, Pahwa S et al (2017) Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: preliminary findings from a multi-institutional study. J Magn Reson Imaging 46:184–193PubMed Ginsburg SB, Algohary A, Pahwa S et al (2017) Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: preliminary findings from a multi-institutional study. J Magn Reson Imaging 46:184–193PubMed
50.
go back to reference Sakai I, Harada K, Hara I, Eto H, Miyake H (2005) A comparison of the biological features between prostate cancers arising in the transition and peripheral zones. BJU Int 96:528–532PubMed Sakai I, Harada K, Hara I, Eto H, Miyake H (2005) A comparison of the biological features between prostate cancers arising in the transition and peripheral zones. BJU Int 96:528–532PubMed
51.
go back to reference Sakai I, Harada K, Kurahashi T, Yamanaka K, Hara I, Miyake H (2006) Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones. Int J Urol 13:368–372PubMed Sakai I, Harada K, Kurahashi T, Yamanaka K, Hara I, Miyake H (2006) Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones. Int J Urol 13:368–372PubMed
52.
go back to reference Greer MD, Lay N, Shih JH et al (2018) Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader study. Eur Radiol 10:4407–4417 Greer MD, Lay N, Shih JH et al (2018) Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader study. Eur Radiol 10:4407–4417
53.
go back to reference Wang NN, Fan RE, Leppert JT et al (2018) Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy. Res Rep Urol 10:233–235PubMedPubMedCentral Wang NN, Fan RE, Leppert JT et al (2018) Performance of multiparametric MRI appears better when measured in patients who undergo radical prostatectomy. Res Rep Urol 10:233–235PubMedPubMedCentral
Metadata
Title
Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer
Authors
Jeroen Bleker
Thomas C. Kwee
Rudi A. J. O. Dierckx
Igle Jan de Jong
Henkjan Huisman
Derya Yakar
Publication date
01-03-2020
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 3/2020
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-019-06488-y

Other articles of this Issue 3/2020

European Radiology 3/2020 Go to the issue